What question did this study set out to answer?

February 11, 2026LeukemiaOpen Access

Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia

View Full Paper

Ask AI

Bookmark

Authors

Analysis finds myelodysplasia-related gene mutations impact survival in FLT3-ITD AML, suggesting risk stratification.

To evaluate the prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia.
Utilized data from 4,078 AML patients in the HARMONY platform.
Identified 862 patients with FLT3-ITD mutations undergoing intensive chemotherapy.
Examined co-occurring myelodysplasia-related gene mutations and their association with survival outcomes.
Only 20% of FLT3-ITD patients had co-occurring myelodysplasia-related gene mutations.
In FLT3-ITD/NPM1 wildtype AML, MRG mutations predicted shorter relapse-free survival (HR 1.37) and overall survival (HR 1.34).
MRG mutations did not impact survival in FLT3-ITD/NPM1 co-mutated subgroup (9% prevalence).

Mecklenbrauck et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark